BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2326302)

  • 21. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
    Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
    Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmortem screening for fatty acid oxidation disorders by analysis of Guthrie cards with tandem mass spectrometry in sudden unexpected death in infancy.
    Wilcox RL; Nelson CC; Stenzel P; Steiner RD
    J Pediatr; 2002 Dec; 141(6):833-6. PubMed ID: 12461502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy.
    Westermann CM; Dorland L; Votion DM; de Sain-van der Velden MG; Wijnberg ID; Wanders RJ; Spliet WG; Testerink N; Berger R; Ruiter JP; van der Kolk JH
    Neuromuscul Disord; 2008 May; 18(5):355-64. PubMed ID: 18406615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When do gut flora in the newborn produce 3-phenylpropionic acid? Implications for early diagnosis of medium-chain acyl-CoA dehydrogenase deficiency.
    Bennett MJ; Bhala A; Poirier SF; Ragni MC; Willi SM; Hale DE
    Clin Chem; 1992 Feb; 38(2):278-81. PubMed ID: 1541011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medium-chain acyl-CoA dehydrogenase deficiency.
    Millington DS; Roe CR
    N Engl J Med; 1989 May; 320(18):1219. PubMed ID: 2710197
    [No Abstract]   [Full Text] [Related]  

  • 26. Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency.
    Pourfarzam M; Morris A; Appleton M; Craft A; Bartlett K
    Lancet; 2001 Sep; 358(9287):1063-4. PubMed ID: 11589939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of urinary medium chain acyl glycines by gas chromatography--negative ion chemical ionization mass spectrometry.
    Carter SM; Midgley JM; Watson DG; Logan RW
    J Pharm Biomed Anal; 1991; 9(10-12):969-75. PubMed ID: 1822221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes.
    Roe CR; Millington DS; Maltby DA; Kinnebrew P
    J Pediatr; 1986 Jan; 108(1):13-8. PubMed ID: 3944676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medium-chain acyl-CoA dehydrogenase deficiency: a useful diagnosis five years after death.
    Bennett MJ; Pollitt RJ; Taitz LS; Variend S
    Clin Chem; 1990 Sep; 36(9):1695-7. PubMed ID: 2208722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry.
    Chace DH; Hillman SL; Van Hove JL; Naylor EW
    Clin Chem; 1997 Nov; 43(11):2106-13. PubMed ID: 9365395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with the 3-phenylpropionic acid loading test for diagnosis of medium-chain acyl-CoA dehydrogenase deficiency (MCADD).
    Lehnert W
    Padiatr Padol; 1993; 28(1):9-12. PubMed ID: 8446429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole blood levels of dodecanoic acid, a routinely detectable forensic marker for a genetic disease often misdiagnosed as sudden infant death syndrome (SIDS): MCAD deficiency.
    Kemp PM; Little BB; Bost RO; Dawson DB
    Am J Forensic Med Pathol; 1996 Mar; 17(1):79-82. PubMed ID: 8838477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cis-4-decenoic acid in plasma: a characteristic metabolite in medium-chain acyl-CoA dehydrogenase deficiency.
    Duran M; Bruinvis L; Ketting D; de Klerk JB; Wadman SK
    Clin Chem; 1988 Mar; 34(3):548-51. PubMed ID: 3349606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of medium chain acyl CoA dehydrogenase deficiency by measurement of cis-4-decenoic acid in dried blood spots.
    Heales SJ; Leonard JV
    Clin Chim Acta; 1992 Jul; 209(1-2):61-6. PubMed ID: 1395039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative analysis of urinary acylglycines for the diagnosis of beta-oxidation defects using GC-NCI-MS.
    Costa CG; Guérand WS; Struys EA; Holwerda U; ten Brink HJ; Tavares de Almeida I; Duran M; Jakobs C
    J Pharm Biomed Anal; 2000 Jan; 21(6):1215-24. PubMed ID: 10708405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stable isotope dilution method for diagnosis of medium chain acyl-CoA dehydrogenase deficiency.
    Rinaldo P; O'Shea J; Tanaka K
    Lancet; 1987 Nov; 2(8568):1158. PubMed ID: 2890064
    [No Abstract]   [Full Text] [Related]  

  • 37. Neonatal screening for medium--chain acyl-CoA dehydrogenase deficiency.
    Fowler DJ; Picker J; Waisbren SE; Levy HL
    Lancet; 2002 Feb; 359(9306):628. PubMed ID: 11867144
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of phenylpropionic acid as a loading test for medium-chain acyl-CoA dehydrogenase deficiency.
    Seakins JW; Rumsby G
    J Inherit Metab Dis; 1988; 11 Suppl 2():221-4. PubMed ID: 3141707
    [No Abstract]   [Full Text] [Related]  

  • 39. Prenatal diagnosis of medium-chain acyl-CoA dehydrogenase deficiency in family with sudden infant death.
    Bennett MJ; Allison F; Pollitt RJ; Manning NJ; Gray RG; Green A; Hale DE; Coates PM
    Lancet; 1987 Feb; 1(8530):440-1. PubMed ID: 2880228
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of urinary acylglycines by electrospray tandem mass spectrometry in mitochondrial energy metabolism defects and organic acidurias.
    Bonafé L; Troxler H; Kuster T; Heizmann CW; Chamoles NA; Burlina AB; Blau N
    Mol Genet Metab; 2000 Apr; 69(4):302-11. PubMed ID: 10870848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.